Be part of the knowledge.™

Endocrinology

59

LikeLikedUnlike

Episodes 1-15 of 40

Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
CME/CE
Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
- Brian P. McDonough, MD, FAAFP
  Peer
- Silvio Inzucchi, MD
  Peer
- Darren McGuire, MD, MHSc
  Peer
0.50 credits
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
CME/CE
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
- Maria Fleseriu, MD, FACE
  Peer
0.25 credits
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages 
CME/CE
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages 
- Aristides Maniatis, MD
  Peer
- Kari Hosack
  Peer
- Meagan Broeckert
  Peer
- Sam Watson
  Peer
0.50 credits
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
CME/CE
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
- Meena B. Bansal, MD, FAASLD
  Peer
- Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP
  Peer
- Fernando Bril, MD
  Peer
1.00 credits
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
CME/CE
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
- Alejandro A. Rabinstein, MD, FAHA
  Peer
- Richard E. Pratley, MD
  Peer
- Jay H. Shubrook, DO, FACOFP, FAAFP
  Peer
1.00 credits
SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®
SHTG: Decoding the Latest Clinical Trial Outcomes
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
advertisement
SHTG: Defining the Unmet Clinical Need
MinuteCE®
SHTG: Defining the Unmet Clinical Need
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
The Road Ahead: What's on the Horizon for FCS and SHTG Management
MinuteCE®
The Road Ahead: What's on the Horizon for FCS and SHTG Management
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Prof. Kausik Ray
  Peer
1.00 program credits
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
MinuteCE®
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
FCS: Enhancing the Diagnosis
MinuteCE®
FCS: Enhancing the Diagnosis
- Daniel Gaudet, MD, PhD
  Peer
1.00 program credits
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
MinuteCE®
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®
APOC3 Inhibition: A Novel Approach to Lowering TGs
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
advertisement
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®
Latest Clinical Trial Outcomes and Breakthroughs for FCS
- Daniel Gaudet, MD, PhD
  Peer
- Pam R. Taub, MD, FACC, FASPC
  Peer
1.00 program credits
Remnant Cholesterol: The Missing Link in ASCVD risk
MinuteCE®
Remnant Cholesterol: The Missing Link in ASCVD risk
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
MinuteCE®
APOC3 Inhibition: New Frontiers Managing Patients with FCS & SHTG
- Daniel Gaudet, MD, PhD
  Peer
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 credits 9 episodes

Program Chapters

Segment Chapters

Playlist:

Recommended